Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol

MLA

Grete F. Lauritzsen, et al. “Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol.” Blood, vol. 108, Nov. 2006, p. 2438. EBSCOhost, https://doi.org/10.1182/blood.v108.11.2438.2438.

APA

Grete F. Lauritzsen, Claudia Roberts, Premini Mahendra, Harald Holte, Jan Delabie, Gulnaz Begum, & Sudhir Tauro. (2006). Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol. Blood, 108, 2438. https://doi.org/10.1182/blood.v108.11.2438.2438

Chicago

Grete F. Lauritzsen, Claudia Roberts, Premini Mahendra, Harald Holte, Jan Delabie, Gulnaz Begum, and Sudhir Tauro. 2006. “Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol.” Blood 108 (November): 2438. doi:10.1182/blood.v108.11.2438.2438.